Dr. Perry Ratcliff, one of America's leading periodontists and experts on dental health and gum disease, joined with leading dental professionals to found Rowpar Pharmaceuticals, Inc. in 1991. Rowpar has been satisfying dental professionals and customers ever since.

During Dr. Ratcliff's 50 plus years of clinical practice, he discovered that chlorine dioxide most effectively treats the bacteria and sulfur compounds responsible for gum disease. His discovery led to the creation of the patented and stabilized formula for chlorine dioxide found in CloSYS™.

Located in Scottsdale, Arizona, Rowpar Pharmaceuticals, Inc. is a research, development and marketing organization that provides innovative oral health solutions. Rowpar focuses on servicing the dental, healthcare and over-the-counter consumer markets using its patented stabilized Chlorine Dioxide formula under the CloSYS™ brand. CloSYS, the Complete Oral Health System™, provides users with healthy gums, long-lasting breath protection and a noticeable fresher, cleaner feeling after each use. The company has licensing agreements in the United Kingdom and distributes throughout the United States and Canada, through dentists, retail outlets and online.

Rowpar Pharmaceuticals, Inc. currently has no open employment positions.